Bausch Health (TSX:BHC) Long-Term Debt : C$29,432 Mil (As of Dec. 2023)

View and export this data going back to 1987. Start your Free Trial

What is Bausch Health Long-Term Debt?

Bausch Health's Long-Term Debt for the quarter that ended in Dec. 2023 was C$29,432 Mil.

Bausch Health's quarterly Long-Term Debt increased from Jun. 2023 (C$26,715 Mil) to Sep. 2023 (C$29,625 Mil) but then declined from Sep. 2023 (C$29,625 Mil) to Dec. 2023 (C$29,432 Mil).

Bausch Health's annual Long-Term Debt declined from Dec. 2021 (C$28,997 Mil) to Dec. 2022 (C$27,624 Mil) but then increased from Dec. 2022 (C$27,624 Mil) to Dec. 2023 (C$29,432 Mil).

Bausch Health Long-Term Debt Historical Data

The historical data trend for Bausch Health's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Long-Term Debt Chart

Bausch Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

32,476.07

30,645.53

28,997.12

27,623.74

29,432.02

Bausch Health Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															27,623.74	27,649.24	26,715.49	29,624.77	29,432.02

Bausch Health (TSX:BHC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Bausch Health Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Bausch Health's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch Health (TSX:BHC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (TSX:BHC) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

BHC:USA BVF:Germany

Address

2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8

Website

https://www.bauschhealth.com

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.